Human Coagulation Factor Ⅷ (Jiangxi Boya Bio-Pharmaceutical )

人凝血因子Ⅷ（江西博雅生物制药）

Report date: 2022/08/15 13:46:57

Base Information

Drug NameHuman Coagulation Factor Ⅷ (Jiangxi Boya Bio-Pharmaceutical )
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemorrhageHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2022/08/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A